S&P lowers outlook for Jubilant Pharma to negative, sees weak performance 0 30.03.2022 09:53 Business Standard Operating performance may remain weak due to regulatory issues, says rating agency. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
